AngioDynamics Appoints Eric Honroth as President and CEO Following Planned Leadership Transition

Latham, NY, October 8, 2026 (AngioDynamics) -- AngioDynamics, Inc. (NASDAQ: ANGO) has appointed Eric Honroth as President and Chief Executive Officer and a member of its Board of Directors, effective November 2, 2026. Honroth will succeed Jim Clemmer, who is retiring after ten years leading the medical technology company and will remain in a consulting role to support the transition. Honroth brings more than 20 years of leadership experience across the medical device and life sciences industries, including cardiovascular, endovascular, urology, and oncology markets. Most recently, he served as Global President of Life Science at Getinge and previously held senior leadership positions at Abbott Vascular, Becton Dickinson, CareFusion, and Boston Scientific. His appointment is intended to build on AngioDynamics’ growth in medical technology, advance its operational transformation, and drive sustainable revenue growth and profitability.

Read full article here.